Cytax 100mg Injection Specification
- Indication
- breast cancer, non-small cell lung cancer, ovarian cancer,
- Expiration Date
- 2028 Years
- Pacakaging (Quantity Per Box)
- 1
- Medicine Type
- Anti Cancer
- Storage
- Do not store above 25 C.
- Molecular Formula
- Paclitaxel
- Salt Composition
- Paclitaxel
- Usage
- breast cancer, non-small cell lung cancer, ovarian cancer,
Cytax 100mg Injection Trade Information
- Minimum Order Quantity
- 5 Pieces
About Cytax 100mg Injection
Cytax 100mg Injection is an anticancer medication used to treat a variety of cancers, including breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS-related Kaposis sarcoma. It works by disrupting the growth and division of cancer cells, helping to slow or stop the progression of the disease. Depending on the type and stage of cancer, Cytax 100mg Injection may be administered alone or in combination with other chemotherapy medications to enhance treatment effectiveness. This medicine should not be used in patients with severe liver impairment, uncontrolled infections, or significantly low white blood cell or platelet counts. It is generally not recommended for children and adolescents under 18 years of age. Before starting treatment, patients should inform their healthcare provider about any history of heart disease or other medical conditions, as close monitoring may be required during therapy. Serious allergic reactions can occur during administration, making treatment under professional medical supervision essential. Patients of reproductive age should use effective contraception throughout treatment and for at least six months after the final dose to prevent pregnancy-related risks. Additionally, because the formulation may contain alcohol, individuals with alcoholism or alcohol-related health concerns should discuss potential risks with their doctor before receiving Cytax 100mg Injection. Regular monitoring throughout treatment helps ensure safety, manage side effects, and achieve the best possible treatment outcomes.